Literature DB >> 9642232

Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome".

C Cardozo1, R A Kohanski.   

Abstract

The multicatalytic proteinase complex (MPC, proteasome) is assembled from 14 nonidentical protein subunits. It expresses five distinct proteolytic activities, including a chymotrypsin-like activity, cleaving after hydrophobic residues, and a branched chain amino acid-preferring component (BrAAP), cleaving preferentially after branched chain residues. Exposure of cells to interferons leads to replacement of the X, Y, and Z subunits by the LMP2, LMP7, and MECL1 subunits. This "immunoproteasome" is critical to processing of certain antigens. The enzymatic basis for enhanced antigen processing has not been determined. To gain insight into this question, we examined sites and relative rates of cleavage of bonds in denatured, reduced, carboxyamidomethylated lysozyme, a 129-amino acid protein, by MPC from bovine spleen, in which the X, Y, and Z subunits are replaced by LMP2, LMP7, and MECL1. We compared cleavages to those catalyzed by MPC from bovine pituitary, which contains only the X, Y, and Z subunits. We found marked increases in the rates and number of cleavages after branched chain residues in reduced, carboxyamidomethylated lysozyme by the spleen MPC. This was largely due to accelerated cleavages of bonds after a Phi-X-Br motif, where Phi is a hydrophobic residue, X is a small neutral or polar residue, and Br is a branched chain residue. Inhibitors with these structural properties were selective and potent inhibitors of the BrAAP activity of the spleen MPC. The above findings indicate that alterations in activity and substrate specificity of the BrAAP activity are important factors underlying the altered cleavages after hydrophobic residues associated with incorporation of interferon-inducible subunits. The potential relevance of the findings to antigen processing functions of MPC is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642232     DOI: 10.1074/jbc.273.27.16764

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

Review 3.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

4.  Escape mutations alter proteasome processing of major histocompatibility complex class I-restricted epitopes in persistent hepatitis C virus infection.

Authors:  Yoichi Kimura; Toshifumi Gushima; Sharad Rawale; Pravin Kaumaya; Christopher M Walker
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.

Authors:  Uma Malhotra; Fusheng Li; Jessica Nolin; Megan Allison; Hong Zhao; James I Mullins; Steve Self; M Juliana McElrath
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

6.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome.

Authors:  Zhaoqing Yang; Dmitry Gagarin; Georges St Laurent; Neil Hammell; Ian Toma; Chien-An Hu; Ayaka Iwasa; Timothy A McCaffrey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-05-14       Impact factor: 8.311

8.  LMP2-specific inhibitors: chemical genetic tools for proteasome biology.

Authors:  Yik Khuan Ho; Paola Bargagna-Mohan; Marie Wehenkel; Royce Mohan; Kyung-Bo Kim
Journal:  Chem Biol       Date:  2007-04

9.  Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants.

Authors:  U Malhotra; J Nolin; H Horton; F Li; L Corey; J I Mullins; M J McElrath
Journal:  Vaccine       Date:  2009-09-09       Impact factor: 3.641

10.  Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.

Authors:  M Lucchiari-Hartz; P M van Endert; G Lauvau; R Maier; A Meyerhans; D Mann; K Eichmann; G Niedermann
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.